Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation

Takehiko Mori, S. Mori, Y. Kanda, K. Yakushiji, S. Mineishi, Y. Takaue, H. Gondo, M. Harada, H. Sakamaki, T. Yajima, Yasushi Iwao, T. Hibi, Shinichiro Okamoto

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

To evaluate the clinical significance of a cytomegalovirus (CMV) antigenemia assay in the prediction and diagnosis of CMV gastrointestinal (CMV-GI) disease after hematopoietic stem cell transplantation (HSCT), 19 allogeneic HSCT recipients developing CMV-GI disease were retrospectively reviewed. All patients were monitored by a CMV antigenemia assay, at least once weekly after engraftment. The median onset of CMV-GI disease occurred 31 days post transplant (range: 19-62). Only four of 19 patients (21%) developed a positive CMV antigenemia test before developing CMV-GI diseases. Although all 19 patients subsequently developed positive CNIV antigenemia tests during their clinical courses, the values remained at a low-level in nine (47%) patients. Among the 14 patients in whom results of real-time polymerase chain reaction (PCR) were available, seven (50%) yielded positive results of real-time PCR before developing CMV-GI disease. In contrast to the values of CMV antigenemia, all 14 patients exclusively yielded high viral loads (median: 2.8 × 104 copies/ml plasma). We conclude that CMV antigenemia testing has limited value in prediction or early diagnosis of CMV-GI disease, and that real-time PCR could have a more diagnostic significance.

Original languageEnglish
Pages (from-to)431-434
Number of pages4
JournalBone Marrow Transplantation
Volume33
Issue number4
DOIs
Publication statusPublished - 2004 Feb

Fingerprint

Gastrointestinal Diseases
Hematopoietic Stem Cell Transplantation
Cytomegalovirus
Real-Time Polymerase Chain Reaction
Viral Load
Early Diagnosis
Transplants

Keywords

  • CMV antigenemia
  • Cytomegalovirus
  • Gastrointestinal disease
  • Hematopoietic stem cell transplantation
  • Real-time PCR

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. / Mori, Takehiko; Mori, S.; Kanda, Y.; Yakushiji, K.; Mineishi, S.; Takaue, Y.; Gondo, H.; Harada, M.; Sakamaki, H.; Yajima, T.; Iwao, Yasushi; Hibi, T.; Okamoto, Shinichiro.

In: Bone Marrow Transplantation, Vol. 33, No. 4, 02.2004, p. 431-434.

Research output: Contribution to journalArticle

Mori, Takehiko ; Mori, S. ; Kanda, Y. ; Yakushiji, K. ; Mineishi, S. ; Takaue, Y. ; Gondo, H. ; Harada, M. ; Sakamaki, H. ; Yajima, T. ; Iwao, Yasushi ; Hibi, T. ; Okamoto, Shinichiro. / Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. In: Bone Marrow Transplantation. 2004 ; Vol. 33, No. 4. pp. 431-434.
@article{adf5532aa0984854ab33969340b4dd96,
title = "Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation",
abstract = "To evaluate the clinical significance of a cytomegalovirus (CMV) antigenemia assay in the prediction and diagnosis of CMV gastrointestinal (CMV-GI) disease after hematopoietic stem cell transplantation (HSCT), 19 allogeneic HSCT recipients developing CMV-GI disease were retrospectively reviewed. All patients were monitored by a CMV antigenemia assay, at least once weekly after engraftment. The median onset of CMV-GI disease occurred 31 days post transplant (range: 19-62). Only four of 19 patients (21{\%}) developed a positive CMV antigenemia test before developing CMV-GI diseases. Although all 19 patients subsequently developed positive CNIV antigenemia tests during their clinical courses, the values remained at a low-level in nine (47{\%}) patients. Among the 14 patients in whom results of real-time polymerase chain reaction (PCR) were available, seven (50{\%}) yielded positive results of real-time PCR before developing CMV-GI disease. In contrast to the values of CMV antigenemia, all 14 patients exclusively yielded high viral loads (median: 2.8 × 104 copies/ml plasma). We conclude that CMV antigenemia testing has limited value in prediction or early diagnosis of CMV-GI disease, and that real-time PCR could have a more diagnostic significance.",
keywords = "CMV antigenemia, Cytomegalovirus, Gastrointestinal disease, Hematopoietic stem cell transplantation, Real-time PCR",
author = "Takehiko Mori and S. Mori and Y. Kanda and K. Yakushiji and S. Mineishi and Y. Takaue and H. Gondo and M. Harada and H. Sakamaki and T. Yajima and Yasushi Iwao and T. Hibi and Shinichiro Okamoto",
year = "2004",
month = "2",
doi = "10.1038/sj.bmt.1704369",
language = "English",
volume = "33",
pages = "431--434",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation

AU - Mori, Takehiko

AU - Mori, S.

AU - Kanda, Y.

AU - Yakushiji, K.

AU - Mineishi, S.

AU - Takaue, Y.

AU - Gondo, H.

AU - Harada, M.

AU - Sakamaki, H.

AU - Yajima, T.

AU - Iwao, Yasushi

AU - Hibi, T.

AU - Okamoto, Shinichiro

PY - 2004/2

Y1 - 2004/2

N2 - To evaluate the clinical significance of a cytomegalovirus (CMV) antigenemia assay in the prediction and diagnosis of CMV gastrointestinal (CMV-GI) disease after hematopoietic stem cell transplantation (HSCT), 19 allogeneic HSCT recipients developing CMV-GI disease were retrospectively reviewed. All patients were monitored by a CMV antigenemia assay, at least once weekly after engraftment. The median onset of CMV-GI disease occurred 31 days post transplant (range: 19-62). Only four of 19 patients (21%) developed a positive CMV antigenemia test before developing CMV-GI diseases. Although all 19 patients subsequently developed positive CNIV antigenemia tests during their clinical courses, the values remained at a low-level in nine (47%) patients. Among the 14 patients in whom results of real-time polymerase chain reaction (PCR) were available, seven (50%) yielded positive results of real-time PCR before developing CMV-GI disease. In contrast to the values of CMV antigenemia, all 14 patients exclusively yielded high viral loads (median: 2.8 × 104 copies/ml plasma). We conclude that CMV antigenemia testing has limited value in prediction or early diagnosis of CMV-GI disease, and that real-time PCR could have a more diagnostic significance.

AB - To evaluate the clinical significance of a cytomegalovirus (CMV) antigenemia assay in the prediction and diagnosis of CMV gastrointestinal (CMV-GI) disease after hematopoietic stem cell transplantation (HSCT), 19 allogeneic HSCT recipients developing CMV-GI disease were retrospectively reviewed. All patients were monitored by a CMV antigenemia assay, at least once weekly after engraftment. The median onset of CMV-GI disease occurred 31 days post transplant (range: 19-62). Only four of 19 patients (21%) developed a positive CMV antigenemia test before developing CMV-GI diseases. Although all 19 patients subsequently developed positive CNIV antigenemia tests during their clinical courses, the values remained at a low-level in nine (47%) patients. Among the 14 patients in whom results of real-time polymerase chain reaction (PCR) were available, seven (50%) yielded positive results of real-time PCR before developing CMV-GI disease. In contrast to the values of CMV antigenemia, all 14 patients exclusively yielded high viral loads (median: 2.8 × 104 copies/ml plasma). We conclude that CMV antigenemia testing has limited value in prediction or early diagnosis of CMV-GI disease, and that real-time PCR could have a more diagnostic significance.

KW - CMV antigenemia

KW - Cytomegalovirus

KW - Gastrointestinal disease

KW - Hematopoietic stem cell transplantation

KW - Real-time PCR

UR - http://www.scopus.com/inward/record.url?scp=12144288318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144288318&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1704369

DO - 10.1038/sj.bmt.1704369

M3 - Article

C2 - 14676775

AN - SCOPUS:12144288318

VL - 33

SP - 431

EP - 434

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 4

ER -